XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance, Beginning at Dec. 31, 2022 $ 6 $ 492,665 $ (1,355) $ (144,600) $ 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   21     21
Exercise of stock options (shares) 17,356        
Stock-based compensation   3,837     3,837
Other comprehensive income (loss)     1,104   1,104
Net loss       (22,838) (22,838)
Balance, Ending at Mar. 31, 2023 $ 6 496,523 (251) (167,438) 328,840
Balance, Ending (in shares) at Mar. 31, 2023 63,274,732        
Balance, Beginning at Dec. 31, 2022 $ 6 492,665 (1,355) (144,600) 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (44,307)
Balance, Ending at Jun. 30, 2023 $ 6 500,903 (547) (188,907) 311,455
Balance, Ending (in shares) at Jun. 30, 2023 63,458,932        
Balance, Beginning at Mar. 31, 2023 $ 6 496,523 (251) (167,438) 328,840
Balance, Beginning (in shares) at Mar. 31, 2023 63,274,732        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock   31     31
Exercise of stock options and vesting of restricted stock (shares) 135,326        
Purchase of common stock under employee stock purchase plan   338     338
Purchase of common stock under employee stock purchase plan (in shares) 48,874        
Stock-based compensation   4,011     4,011
Other comprehensive income (loss)     (296)   (296)
Net loss       (21,469) (21,469)
Balance, Ending at Jun. 30, 2023 $ 6 500,903 (547) (188,907) 311,455
Balance, Ending (in shares) at Jun. 30, 2023 63,458,932        
Balance, Beginning at Dec. 31, 2023 $ 7 563,487 99 (244,763) $ 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342       70,453,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs $ 2 238,797     $ 238,799
Issuance of common stock, net of offering costs (shares) 22,450,206        
Exercise of stock options   1,926     1,926
Exercise of stock options (shares) 380,980        
Stock-based compensation   4,871     4,871
Other comprehensive income (loss)     (960)   (960)
Net loss       (28,525) (28,525)
Balance, Ending at Mar. 31, 2024 $ 9 809,081 (861) (273,288) 534,941
Balance, Ending (in shares) at Mar. 31, 2024 93,284,528        
Balance, Beginning at Dec. 31, 2023 $ 7 563,487 99 (244,763) $ 318,830
Balance, Beginning (in shares) at Dec. 31, 2023 70,453,342       70,453,342
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         $ (60,022)
Balance, Ending at Jun. 30, 2024 $ 9 816,304 (1,054) (304,785) $ 510,474
Balance, Ending (in shares) at Jun. 30, 2024 93,643,341       93,643,341
Balance, Beginning at Mar. 31, 2024 $ 9 809,081 (861) (273,288) $ 534,941
Balance, Beginning (in shares) at Mar. 31, 2024 93,284,528        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock   1,577     1,577
Exercise of stock options and vesting of restricted stock (shares) 283,039        
Purchase of common stock under employee stock purchase plan   422     422
Purchase of common stock under employee stock purchase plan (in shares) 75,774        
Stock-based compensation   5,224     5,224
Other comprehensive income (loss)     (193)   (193)
Net loss       (31,497) (31,497)
Balance, Ending at Jun. 30, 2024 $ 9 $ 816,304 $ (1,054) $ (304,785) $ 510,474
Balance, Ending (in shares) at Jun. 30, 2024 93,643,341       93,643,341